These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation. Mégraud F; Occhialini A; Doermann HP J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():25-38. PubMed ID: 9440053 [TBL] [Abstract][Full Text] [Related]
4. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children]. Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in Helicobacter pylori. Guslandi M Lancet; 1999 Jan; 353(9148):241-2. PubMed ID: 9923908 [No Abstract] [Full Text] [Related]
6. Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori. Gerrits MM; Godoy AP; Kuipers EJ; Ribeiro ML; Stoof J; Mendonça S; van Vliet AH; Pedrazzoli J; Kusters JG Helicobacter; 2006 Jun; 11(3):181-7. PubMed ID: 16684266 [TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents]. Huang LP; Zhuang ML; Gu CP Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):210-2. PubMed ID: 19292962 [TBL] [Abstract][Full Text] [Related]
8. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Glupczynski Y; Burette A Am J Gastroenterol; 1990 Dec; 85(12):1545-51. PubMed ID: 2174642 [TBL] [Abstract][Full Text] [Related]
9. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori]. Sugita K; Katouno Y; Uchida H; Kobayashi Y Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in Helicobacter pylori: a global overview. Glupczynski Y Acta Gastroenterol Belg; 1998; 61(3):357-66. PubMed ID: 9795473 [TBL] [Abstract][Full Text] [Related]
14. [Characteristics of anti-microbial agents and its clinical choice for H. pylori treatment]. Aoyama N; Shirasaka D; Sakai T; Shirakawa K Nihon Rinsho; 1999 Jan; 57(1):43-52. PubMed ID: 10036934 [TBL] [Abstract][Full Text] [Related]
15. Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles. Kumala W; Rani A Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):970-4. PubMed ID: 17333742 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. Debets-Ossenkopp YJ; Herscheid AJ; Pot RG; Kuipers EJ; Kusters JG; Vandenbroucke-Grauls CM J Antimicrob Chemother; 1999 Apr; 43(4):511-5. PubMed ID: 10350380 [TBL] [Abstract][Full Text] [Related]
17. Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan. Nishizawa T; Suzuki H; Kurabayashi K; Masaoka T; Muraoka H; Mori M; Iwasaki E; Kobayashi I; Hibi T Antimicrob Agents Chemother; 2006 Apr; 50(4):1538-40. PubMed ID: 16569878 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection. Sharara AI; Chaar HF; Racoubian E; Moukhachen O; Barada KA; Mourad FH; Araj GF Helicobacter; 2004 Jun; 9(3):255-61. PubMed ID: 15165262 [TBL] [Abstract][Full Text] [Related]
19. Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori. Siavoshi F; Saniee P; Malekzadeh R Helicobacter; 2018 Dec; 23(6):e12531. PubMed ID: 30230637 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibilities of Helicobacter pylori. Bindayna KM Saudi Med J; 2001 Jan; 22(1):53-7. PubMed ID: 11255612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]